[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

August 2017 - July 1959

Decade

Year

Issue

December 2013, Vol 70, No. 12, Pages 1255-1375

In This Issue of JAMA Psychiatry

Highlights

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1255-1257. doi:10.1001/jamapsychiatry.2013.2021
Viewpoint

Partnership Between Tobacco Control Programs and Offices of Mental Health Needed to Reduce Smoking Rates in the United States

Abstract Full Text
JAMA Psychiatry. 2013;70(12):1261-1262. doi:10.1001/jamapsychiatry.2013.2182
Art and Images in Psychiatry

Lives of the Buddha: Vessantara the Charitable PrinceThai School

Abstract Full Text
JAMA Psychiatry. 2013;70(12):1259-1260. doi:10.1001/jamapsychiatry.2013.2023
Editorial

Psychosis Within vs Outside of Major Mood EpisodesA Key Prognostic and Diagnostic Criterion

Abstract Full Text
JAMA Psychiatry. 2013;70(12):1263-1264. doi:10.1001/jamapsychiatry.2013.2808

Making Progress With Magnetic Resonance Spectroscopy

Abstract Full Text
JAMA Psychiatry. 2013;70(12):1265-1266. doi:10.1001/jamapsychiatry.2013.2615
Original Investigation

Add-on Treatment of Benzoate for SchizophreniaA Randomized, Double-blind, Placebo-Controlled Trial of d-Amino Acid Oxidase Inhibitor

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1267-1275. doi:10.1001/jamapsychiatry.2013.2159

Lane and coauthors examine the clinical and cognitive efficacy and safety of add-on treatment of sodium benzoate for schizophrenia.

Boundaries of Schizoaffective DisorderRevisiting Kraepelin

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1276-1286. doi:10.1001/jamapsychiatry.2013.2350

Kotov et al examine the associations between symptom course and long-term outcome to identify natural boundaries within psychotic disorders. Kendler provides an editorial.

Pathways to Violent Behavior During First-Episode PsychosisA Report From the UK National EDEN Study

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1287-1293. doi:10.1001/jamapsychiatry.2013.2445

Winsper and colleagues aimed to determine whether there are subgroups of psychotic individuals characterized by different developmental trajectories to violent behavior.

Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1294-1302. doi:10.1001/jamapsychiatry.2013.2437

In a combined 3-T structural magnetic resonance imaging and single-voxel proton magnetic resonance spectroscopy study, Kraguljac and coauthors evaluate hippocampal volumetric measures and neurometabolite levels in unmedicated patients with schizophrenia and the correlations between these markers. See the editorial by Öngür.

Independent Modulation of Engagement and Connectivity of the Facial Network During Affect Processing by CACNA1C and ANK3 Risk Genes for Bipolar Disorder

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1303-1311. doi:10.1001/jamapsychiatry.2013.2099

Dima et al determine whether genetic risk for bipolar disorder associated with CACNA1C rs1006737 and ANK3 rs10994336 is mediated through changes in regional activation and interregional connectivity of the facial affect–processing network.

Maternal Depression During Pregnancy and the Postnatal PeriodRisks and Possible Mechanisms for Offspring Depression at Age 18 Years

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1312-1319. doi:10.1001/jamapsychiatry.2013.2163

Pearson et al investigate the hypothesis that there are independent associations between antenatal and postnatal depression with offspring depression and that the risk pathways are different.

Brainstem Aminergic Nuclei and Late-Life Depressive Symptoms

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1320-1328. doi:10.1001/jamapsychiatry.2013.2224

To test the hypothesis that neurodegeneration and neuronal density in brainstem aminergic nuclei are related to late-life depression, Wilson et al performed a clinicopathological cohort study among 124 older persons without dementia who had annual evaluations (with self-report of depressive symptoms), died, and underwent a postmortem neuropathological examination.

Attention Network Hypoconnectivity With Default and Affective Network Hyperconnectivity in Adults Diagnosed With Attention-Deficit/Hyperactivity Disorder in Childhood

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1329-1337. doi:10.1001/jamapsychiatry.2013.2174

McCarthy et al compare adults with a childhood diagnosis of attention-deficit/hyperactivity disorder (ADHD) and control subjects to determine the specific location of possible ADHD-related differences in resting-state functional connectivity.

Topiramate for the Treatment of Cocaine AddictionA Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1338-1346. doi:10.1001/jamapsychiatry.2013.2295

Johnson et al determine the efficacy of topiramate vs placebo as a treatment for cocaine dependence.

A Randomized, Double-blind Evaluation of Buprenorphine Taper Duration in Primary Prescription Opioid Abusers

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1347-1354. doi:10.1001/jamapsychiatry.2013.2216

Sigmon et al evaluate the relative efficacy of 1-, 2-, and 4-week buprenorphine tapering regimens and subsequent naltrexone therapy in outpatients with prescription opioid dependence.

State Parity Laws and Access to Treatment for Substance Use Disorder in the United StatesImplications for Federal Parity Legislation

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1355-1362. doi:10.1001/jamapsychiatry.2013.2169

Wen et al examine the effect of state-level substance use disorder (SUD) parity laws on state-aggregate SUD treatment rates and the effect of recent federal SUD parity legislation.

Addressing Risks to Advance Mental Health Research

Abstract Full Text
free access has expired quiz
JAMA Psychiatry. 2013;70(12):1363-1371. doi:10.1001/jamapsychiatry.2013.2105

Iltis et al provide mental health researchers with practical approaches to (1) identify and define various intrinsic research risks, (2) communicate these risks to others (eg, potential participants, regulatory bodies, and society), (3) manage these risks during the course of a study, and (4) justify the risks.

Comment & Response

A Leap of Faith in Antidepressant Treatment?

Abstract Full Text
JAMA Psychiatry. 2013;70(12):1373. doi:10.1001/jamapsychiatry.2013.2114

Antidepressant Medication and Spontaneous Abortion“No Significant Association”? Clinically Significant Association!

Abstract Full Text
JAMA Psychiatry. 2013;70(12):1373-1374. doi:10.1001/jamapsychiatry.2013.2274

Developmental MismatchWhy Some Immigrants Seem Protected From Affective, Personality, and Substance Use Disorders

Abstract Full Text
JAMA Psychiatry. 2013;70(12):1374-1375. doi:10.1001/jamapsychiatry.2013.2180

Toward a Genuinely Patient-Centered Metric of Depression RecoveryOne Step Further

Abstract Full Text
JAMA Psychiatry. 2013;70(12):1375. doi:10.1001/jamapsychiatry.2013.2187
Correction

Error in Author Name

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1375. doi:10.1001/jamapsychiatry.2013.3787
JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(12):1258. doi:10.1001/jamapsychiatry.2013.2019
×